Table 2 Medication in the study groups at baseline

Antihypertensive agents (n (%))

 Angiotensin II receptor blockers

12 (86)

10 (71)

0.324

 Angiotensin-converting enzyme inhibitors

2 (14)

0 (0)

0.241

 Calcium-channel blockers

10 (71)

8 (57)

0.430

 Diuretics

4 (29)

3 (21)

0.500

 β-blockers

4 (29)

3 (21)

0.500

 α-blockers

1 (7)

0 (0)

0.500

 Central sympatholytic agents

0 (0)

1 (7)

0.500

Glucose-lowering agents (n (%))

 Insulin and insulin analougues

0 (0)

0 (0)

-

 Sulfonylureas

0 (0)

2 (14)

0.241

 α-glucosidase inhibitors

3 (21)

1 (7)

0.298

 Biguanides

1 (7)

0 (0)

0.500

 Thiazolidinediones

0 (0)

1 (7)

0.500

Lipid-lowering agents (n (%))

0 (0)

0 (0)

-

Antiplatelet agents (n (%))

2 (14)

3 (21)

0.500